Research programme: botulinum toxin vaccine - Emergent BioSolutions

Drug Profile

Research programme: botulinum toxin vaccine - Emergent BioSolutions

Alternative Names: Bivalent botulinum vaccine; rBOT

Latest Information Update: 12 Sep 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Emergent BioSolutions; Health Protection Agency Porton Down
  • Developer Emergent BioSolutions
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Botulism

Most Recent Events

  • 12 Sep 2014 No development reported - Preclinical for Botulism in USA and United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top